Brazilian Zika virus strain causes birth defects in experimental modelsMay 12, 2016
Researchers at University of California San Diego School of Medicine, with colleagues in Brazil and Senegal, have described the first "direct experimental proof" that the Brazilian strain of Zika virus can actually cause severe birth defects. The findings are published in the May 11 online issue of Nature.
The team, headed by Alysson R. Muotri, PhD, associate professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine, and co-corresponding senior author Patricia C.B. Beltrao-Braga, PhD, at the University of Sao Paulo, conducted studies in mouse models, human stem cells and in cerebral organoids - miniature brains grown in vitro.
"Rising infection rates of Zika virus in places like Brazil, with a corresponding increase in cases of microcephaly, have powerfully suggested an association, but until now hard evidence has been lacking," said Muotri. "Our findings provide direct experimental proof that the Brazilian Zika virus strain causes severe birth defects - and that the full adverse effect upon health, even beyond microcephaly, is not yet fully understood."
Muotri said the model developed to determine Zika cause-and-effect provides a new tool to assess the effectiveness of potential therapies to counteract the virus during human neurodevelopment.
"Our platform can now be used to understand what is unique about the Brazilian Zika virus and to test drugs to prevent the neurological problems associated with the infection," he said. "Moreover, we now have a robust animal model that will be useful during validation of potential vaccines against the virus."
The Zika virus is not new. It was first described in 1947 in rhesus monkeys in Uganda, but researchers say the twin lineages of Zika - African and Asian - did not cause meaningful infections in humans until 2007, when the Asian strain, carried by Aedes aegypti mosquitoes, caused an epidemic on the Pacific island of Yap. Further outbreaks occurred in New Caledonia and French Polynesia from 2013 to 2015.
In 2013, the Asian lineage of Zika reached Brazil and subsequently other countries in South and Central America. In Brazil, the virus has aroused international attention and concern, with infections of pregnant women alarmingly linked to congenital malformations, including microcephaly (an undersized head and brain) in newborns and other severe neurological diseases, such as Guillain-Barre syndrome.
In the Nature paper, authors used mouse models to track Brazilian virus infections to birth defects. "This is the first animal model to document Zika-induced birth defects. It shows that the virus can cross the placenta membrane and infect the fetus," said Muotri. Like humans, newborn mouse pups infected via their mothers with the Brazilian Zika virus strain displayed smaller-than-normal heads and stunted body growth. Tissue and genetic analyses revealed other abnormalities, including eye problems and ongoing cell death.
"The data in mice also suggest that microcephaly is only the tip of the iceberg. The animals have extensive intra-uterine growth arrest, which essentially means poor fetal development in the womb. Media covering the Zika story have focused upon affected babies with small heads because such images are profoundly dramatic, but the true health impact is likely to be more widespread and devastating."
Interestingly, Muotri noted that not all mouse models tested showed a causal effect when infected by the Zika virus. In at least one strain of mice, the Brazilian Zika virus could not cross the placenta of the mother to infect her unborn pups. Muotri said the finding suggests that in mice - and humans - some individuals may be more susceptible to infection than others, possibly due to genetic differences or varying robustness of the immune system response.
The researchers also conducted studies using human pluripotent stem cells to generate cortical progenitor cells that ordinarily would differentiate into neurons forming the brain's cerebral cortex or folded outer layer. Infection of these cortical progenitor cells by the Brazilian viral strain resulted in increased progenitor cell death. The effects of the African virus is not as pronounced, indicating that the mutations of the Brazilian strains made the virus more aggressive in human cells.
Finally, researchers exposed human brain organoids - three-dimensional buds of cells created from pluripotent stem cells that structurally represent specific organs writ small - to the Zika virus. They noted that infection resulted in reduced areas of growth in the organoids and disrupted cortical layers. Again, the Brazilian virus had a more dramatic impact on cortical malformations in these human organoids.
Muotri said they tested the Brazilian Zika virus in organoids derived from chimpanzees to assess its adaptability compared to the African strain. "The Brazilian virus has a slow replication rate in the chimp organoid compared to the African virus," Muotri said, "which suggests that the Brazilian strain has, somehow, adapted to humans. We are investigating how genetic differences might cause that difference."
Co-authors of the study include: Fernanda R. Cugola, JoĂ£o Leonardo MendonĂ§a Dias, Katia O. P. GuimarĂ£es, Cecilia Benizzato, Nathalia Santos, Carolina Manganeli Polonio, Isabela Cunha, Carla Longo Freitas, Wesley Nogueira BrandĂ£o, Cristiano Rossato, David Garrido Andrade, Daniele de Paula Faria, Alexandre Teles Garcez, Carlos Alberto Buchpigel, Carla Torres Braconi, Erica Mendes, Paolo M. de A. Zanotto, and Jean Pierre Schatzmann, all at the University of Sao Paolo, Brazil; Isabella Rodrigues Fernandes, University of Sao Paolo and UC San Diego; Fabiele Baldino Russo, and Graciela C. Pignatari, University of Sao Paolo and Tismoo Biotechnology Company, Sao Paolo; Beatriz C. Freitas, and Sarah Romero, UC San Diego; and Amadou Alpha Sall, Institute Pasteur, Senegal.
Funding for this research came, in part, from the Zika Network FAPESP Projects, the Tooth Fairy Project and the National Institutes of Health (U19MH107367) and NARSAD.
University of California - San Diego
Related Zika Virus Current Events and Zika Virus News Articles
How Zika infects the placenta
Zika virus can infect and replicate in immune cells from the placenta, without killing them, scientists have discovered. The finding may explain how the virus can pass through the placenta of a pregnant woman, on its way to infect developing brain cells in her fetus.
Zika virus infects human placental macrophages
One of Zika's mysteries is how the virus passes from an infected mother, through the placenta, to a developing fetus.
Predicting the spread of the Zika virus
A new tool by Japan-based researchers predicts the risk of Zika virus importation and local transmission for 189 countries.
Study identifies risk factors associated with eye abnormalities in infants with presumed Zika virus
In a study published online by JAMA Ophthalmology, Rubens Belfort Jr., M.D., Ph.D., of the Federal University of Sao Paulo and Vision Institute, Sao Paulo, Brazil, and colleagues assessed and identified possible risk factors for ophthalmoscopic (an instrument used to visualize the back of the eye) findings in infants born with microcephaly (a birth defect characterized by an abnormally small head) and a presumed clinical diagnosis of Zika virus intrauterine infection.
Zika conspiracy theories on social media putting vulnerable people at risk
Conspiracy theories and pseudoscientific claims refuting the facts around Zika virus vaccines could be putting vulnerable people at risk, according to a new study published in Vaccine.
Zika virus may be linked to more eye problems in Brazilian babies with microcephaly
Researchers studying babies with a Zika virus-related birth defect say they have found previously unreported eye problems possibly linked to the virus that could result in severe visual impairment.
A tool to support public health decisions on Zika virus predicts most planned interventions to be cost-effective
A study published in PLOS Neglected Tropical Diseases presents a cost-effectiveness tool that can help guide decisions regarding resource allocation to fund interventions targeted at curtailing the ongoing Zika virus outbreak.
Researchers solve the structure of the Zika virus helicase
A team led by researchers from Tianjin University (P.R. China) has solved the structure of the Zika virus helicase, which is a key target for antiviral development. The research is published in Springer's journal Protein & Cell.
Zika virus protein could be vaccine target
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health (NIH) scientists and colleagues at Mount Sinai's Icahn School of Medicine. Their study, published online May 19, 2016 in Cell Host & Microbe, suggests that altering or removing the NS5 protein from Zika virus would allow the human body's own immune defenses to attack the virus.
Yale study: How antibodies access neurons to fight infection
Yale scientists have solved a puzzle of the immune system -- how antibodies enter the nervous system to control viral infections.
More Zika Virus Current Events and Zika Virus News Articles